PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>42</strong>/<strong>2000</strong><br />
15278 <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 19 Oct/oct <strong>2000</strong><br />
(51) 7 C12N 15/00<br />
(11) WO 00/61736 (13) A2<br />
(21) <strong>PCT</strong>/US00/09518<br />
(22) 7 Apr/avr <strong>2000</strong> (07.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 09/289,254 9 Apr/avr 1999 US<br />
(09.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) NOVEL RECOMBINANT AND MU-<br />
TANT HERPESVIRUSES<br />
NOUVEAUX HERPESVIRUS RECOM-<br />
BINANTS ET MUTANTS<br />
(63) US 09/289,254 (CON)<br />
9 Apr/avr 1999 (09.04.1999)<br />
(71) SCHERING–PLOUGH LTD. [CH/CH];<br />
Toepferstrasse 5, CH–6004 Lucerne (CH).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) JUNKER, David, E. [US/US]; 6901<br />
Galewood Street, San Diego, CA 92120<br />
(US).<br />
(74) FOULKE, Cynthia, L. et al. / etc.;<br />
Schering–Plough Corporation, Patent Dept.<br />
K–6–1 1990, <strong>2000</strong> Galloping Hill Road,<br />
Kenilworth, NJ 07033–0530 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CZ DE DK DM DZ EE<br />
ES FI GB GD GE HR HU ID IL IN IS JP<br />
KG KR KZ LC LK LR LT LU LV MA MD<br />
MG MK MN MX NO NZ PL PT RO RU SE<br />
SG SI SK SL TJ TM TR TT TZ UA US UZ<br />
VN YU ZA; AP (GH GM KE LS MW SD<br />
SL SZ TZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE); OA (BF BJ CF CG CI CM GA GN<br />
GW ML MR NE SN TD TG).<br />
(51) 7 C12N 15/00<br />
(11) WO 00/61737<br />
(21) <strong>PCT</strong>/US00/09695<br />
(13) A2<br />
(22) 12 Apr/avr <strong>2000</strong> (12.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 60/129,006 13 Apr/avr 1999<br />
(13.04.1999)<br />
US<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) PRODUCTION OF ATTENUATED<br />
NEGATIVE STRANDED RNA VIRUS<br />
VACCINES FROM CLONED NUCLEO-<br />
TIDE SEQUENCES<br />
ELABORATION DE VACCINS DE<br />
VIRUS A ARN NEGATIF SOUS<br />
FORME ATTENUEE A PARTIR DE<br />
SEQUENCES<br />
CLONEES<br />
NUCLEOTIDIQUES<br />
(71) THE GOVERNMENT OF THE UNITED<br />
STATES OF AMERICA represented by<br />
THE DEPARTMENT OF HEALTH AND<br />
HUMAN SERVICES [US/US]; 6011 Executive<br />
Boulevard, Suite 325, Rockville, MD<br />
20852 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) MURPHY, Brian, R. [US/US]; 5410<br />
Tuscawaras Road, Bethesda, MD 20816<br />
(US). COLLINS, Peter, L. [US/US];<br />
12304 Village Square #401, Rockville, MD<br />
20852 (US). DURBIN, Anna, P. [US/US];<br />
806 Hudson Avenue, Takoma Park, MD<br />
20912 (US). SKIADOPOULOS, Mario, H.<br />
[US/US]; 8303 Aqueduct Road, Potomac,<br />
MD 20854 (US).<br />
(74) KING, Jeffrey, J. et al. / etc.; Townsend<br />
and Townsend and Crew, LLP, Two Embarcadero<br />
Center, 8th Floor, San Francisco, CA<br />
94111–3834 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 C12N 15/00<br />
(11) WO 00/61738 (13) A2<br />
(21) <strong>PCT</strong>/US00/09766<br />
(22) 12 Apr/avr <strong>2000</strong> (12.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 60/128,887 12 Apr/avr 1999<br />
(12.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
US<br />
(54) DIFFERENTIAL REGULATION OF<br />
GENE EXPRESSION IN ONCOGENIC<br />
TRANSFORMATION<br />
REGULATION DIFFERENTIELLE DE<br />
L’EXPRESSION GENIQUE DANS UNE<br />
TRANSFORMATION ONCOGENE<br />
(71) DIGITAL GENE TECHNOLOGIES,<br />
INC. [US/US]; Suite 110, 11149 <strong>No</strong>rth<br />
Torrey Pines Road, La Jolla, CA 92037<br />
(US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) VOGT, Peter, K. [US/US]; 7909 St.<br />
Louis Terrace, La Jolla, CA 92037 (US).<br />
FU, Shu–ling [–/US]; Apartment 47, 3222<br />
Caminito Eastbluff, La Jolla, CA 92037<br />
(US). HILBUSH, Brian, S. [US/US]; 13058<br />
Caminito Angelico, San Diego, CA 92130<br />
(US). BOTTOLI, Ivan, L., C. [CH/US]; 938<br />
Wind Drift Drive, Carlsbad, Ca 92009 (US).<br />
DICKERSON, Janet, C. [US/US]; 9818<br />
Caminito Doha, San Diego, CA 92131 (US).<br />
(74) ZIMMERMAN, Roger, P.; McDonnell<br />
Boehnen Hulbert & Berghoff, Suite 3200,<br />
300 South Wacker Drive, Chicago, IL 60606<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 C12N 15/09, C12P 21/00, 21/08, A61K<br />
39/00, G01N 33/53<br />
(11) WO 00/61739<br />
(21) <strong>PCT</strong>/JP00/02260<br />
(13) A1<br />
(22) 7 Apr/avr <strong>2000</strong> (07.04.<strong>2000</strong>)<br />
(25) ja (26) ja<br />
(30) 11/103158 9 Apr/avr 1999<br />
(09.04.1999)<br />
JP<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
(54) METHOD FOR CONTROLLING THE<br />
ACTIVITY OF IMMUNOLOGICALLY<br />
FUNCTIONAL MOLECULE<br />
METHODE DE REGULATION DE<br />
L’ACTIVITE D’UNE MOLECULE<br />
IMMUNOLOGIQUEMENT<br />
TIONNELLE<br />
FONC-<br />
(71) KYOWA HAKKO KOGYO CO.,<br />
LTD. [JP/JP]; 6–1, Ohtemachi 1–chome,<br />
Chiyoda–ku, Tokyo 100–8185 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) HANAI, <strong>No</strong>buo [JP/JP]; Tokyo Research<br />
Laboratories, Kyowa Hakko Kogyo<br />
Co., Ltd., 6–6, Asahi–machi 3–chome,<br />
Machida–shi, Tokyo 194–8533 (JP). NA-<br />
KAMURA, Kazuyasu [JP/JP]; Tokyo<br />
Research Laboratories, Kyowa Hakko Kogyo<br />
Co., Ltd., 6–6, Asahi–machi 3–chome,<br />
Machida–shi, Tokyo 194–8533 (JP). SHOJI,<br />
Emi [JP/JP]; Tokyo Research Laboratories,<br />
Kyowa Hakko Kogyo Co., Ltd., 6–6,<br />
Asahi–machi 3–chome, Machida–shi, Tokyo<br />
194–8533 (JP). YAMASAKI, Motoo<br />
[JP/JP]; Tokyo Research Laboratories,<br />
Kyowa Hakko Kogyo Co., Ltd., 6–6,<br />
Asahi–machi 3–chome, Machida–shi, Tokyo<br />
194–8533 (JP). UCHIDA, Kazuhisa<br />
[JP/JP]; Tokyo Research Laboratories,<br />
Kyowa Hakko Kogyo Co., Ltd., 6–6,<br />
Asahi–machi 3–chome, Machida–shi, Tokyo<br />
194–8533 (JP). SHINKAWA, Toyohide<br />
[JP/JP]; Tokyo Research Laboratories,<br />
Kyowa Hakko Kogyo Co., Ltd., 6–6,<br />
Asahi–machi 3–chome, Machida–shi, Tokyo<br />
194–8533 (JP). IMABEPPU, Susumu<br />
[JP/JP]; Toxicological Research Laboratories,<br />
Kyowa Hakko Kogyo Co., Ltd., 2548,<br />
Ohaza–Fujimagari, Ube–shi, Yamaguchi<br />
755–8501 (JP). KANDA, Yutaka [JP/JP];<br />
Tokyo Research Laboratories, Kyowa<br />
Hakko Kogyo Co., Ltd., 6–6, Asahi–machi<br />
3–chome, Machida–shi, Tokyo 194–8533<br />
(JP). YAMANE, Naoko [JP/JP]; Tokyo<br />
Research Laboratories, Kyowa Hakko Kogyo<br />
Co., Ltd., 6–6, Asahi–machi 3–chome,<br />
Machida–shi, Tokyo 194–8533 (JP). ANA-<br />
ZAWA, Hideharu [JP/JP]; Tokyo Research